ENVISION SUMMIT 2023

COORDINATION

Dr. Mafalda Oliveira, Hospital Vall d’Hebron/VHIO, Barcelona and President of SOLTI

Dr. Tomás Pascual, SOLTI’s Medical Director

AGENDA

10:00 – Welcome
Coordinators

10:10 – Tumor biology to escalate or de-escalate therapy in HER2+ breast cancer
Dr. Roisin Connolly (UCC Cancer Trials Group)

10:40 – Discussion
Dr. Roisin Connolly (UCC Cancer Trials Group), coordinators

10:55 – Spotlight on Immuno-oncology conceptualizing the right approaches for
breast cancer subtypes
Dr. Giuseppe Curigliano (European Institute of Oncology, IRCCS)

11:25 – Discussion
Dr. Giuseppe Curigliano (European Institute of Oncology, IRCCS), coordinators

11:40 – Break

12:10 – Improved uses of classical and novel CDKs in cancer therapy
Dr. Marcos Malumbres (Vall d’Hebron Institute of Oncology, Barcelona)

12:40 – Discussion
Dr. Marcos Malumbres (Vall d’Hebron Institute of Oncology, Barcelona), coordinators

12:55 – No more triple negative breast cancer: molecular classification and
personalised therapy
Dr. Christos Sotiriou, (Jules Bordet Institute)

13:25 – Discussion
Dr. Christos Sotiriou, (Jules Bordet Institute), coordinators

13:25 – Conclusions and closure

13:45 – Lunch